US fund Platinum acquires Inventia Health in India foray

Platinum Equity makes its debut in India by acquiring a majority stake in Mumbai's Inventia Healthcare. With a valuation of Rs 2,500 crore, the deal sees PE investors exiting while the promoter retains a minority stake. Platinum Equity, managing over $48 billion in assets, is well-known for its expertise in the healthcare sector.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZldEqhQ
via IFTTT

Read More

India's healthcare in critical condition: 4 out of 5 public health centers below par, reveals new Govt report

A recent Indian government self-assessment reveals that most public health facilities, including district hospitals and primary centers, fall short of essential standards. Only 20% meet benchmarks for infrastructure and resources, with 42% scoring below 50%. Initiatives aim to bring 70,000 facilities to standard within 100 days, backed by inspections and funding under the National Health Mission. This highlights urgent reforms needed to enhance healthcare nationwide, promising better services and equity in healthcare delivery.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Sge160z
via IFTTT

Read More

HCG acquires Vizag based cancer hospital for enterprise valuation of Rs 414 crore

HCG, India's leading cancer care chain, acquired a majority stake in Visakhapatnam's Mahatma Gandhi Cancer Hospital for Rs 414 crore. The deal begins with a 51% ownership, aiming to complete 85% in 18 months. The hospital's FY24 revenue was Rs 120.2 crore with an EBITDA of Rs 42.2 crore, expected to boost HCG's annual EBITDA by Rs 3 per share and consolidate its position in the Vizag region.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/JdwW6tB
via IFTTT

Read More

India to make drugs for diabetes, obesity under PLI by 2026, says report

The Indian government plans to introduce a production-linked incentive (PLI) program in 2026 to boost domestic manufacturing of GLP-1 drugs, used for treating diabetes and obesity. The anti-obesity medication market is projected to reach $100 billion by 2030, as per Goldman Sachs Research. Major Indian pharmaceutical companies like Sun Pharmaceutical Industries Ltd., Cipla Ltd., and Dr. Reddy’s Laboratories Ltd. are developing weight-loss formulations and generic drugs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZEV8iPJ
via IFTTT

Read More

Why self-medicating without consulting a dermatologist is a bad idea

The pursuit of flawless skin through unguided skincare practices, influenced by social media and beauty trends, can result in adverse reactions. Seeking professional advice before experimenting with potent products is crucial to prevent skin damage and maintain skin health.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/FG4xpLY
via IFTTT

Read More

Risk-based audits of drug units to begin from July 1

The revised Schedule M, which is considered more stringent than the World Health Organization's (WHO) good manufacturing practices (GMP) in certain areas, was notified on December 28, 2023. Companies with turnover of over ₹250 crore will have to comply with the upgraded version of Schedule M, starting July 1, and the remaining others, which are largely micro, small, and medium enterprises (MSMEs), have been given a year's time to comply. Inspections on those firms will begin from January 1, 2025.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/erNkOYW
via IFTTT

Read More

WHO warns alarming levels of physical inactivity among Indians, says women more physically inactive than men

A study in The Lancet Global Health highlights that nearly 50% of Indian adults are physically inactive, posing severe health risks. The study shows a significant rise in inactivity from 2000 to 2022, with women being more affected than men. City doctors attribute this to sedentary office work and poor diets. The lack of physical activity increases the risk of cardiovascular diseases, cancers, and psychological issues. Experts stress the need for regular exercise and healthier lifestyles to address this growing concern.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OerSyTk
via IFTTT

Read More